Introduction
Nocardia cyriacigeorgica (initially described as 'Nocardia cyriacigeorgici') was first reported in 2001 from a patient with chronic bronchitis (Yassin et al., 2001) . Nocardia species are branching Gram-positive bacilli belonging to the family Nocardiaceae, together with the genus Rhodococcus, within the suborder Corynebacterineae of the Actinobacteria (Stackebrandt et al., 1997) . They are related to the families Mycobacteriaceae, Gordoniaceae, Tsukamurellaceae and Dietziaceae. The Nocardia cell wall contains tuberculostearic acids, like Mycobacteria, but also short chain mycolic acids (Brown-Elliott et al., 2006) . They are common environmental organisms worldwide, although some species show some geographical variance in prevalence (Brown-Elliott et al., 2006) . The introduction of molecular typing methods led to the specification of the Nocardia asteroides complex between defined antimicrobial-susceptibility patterns, with for example type I susceptibility patterns corresponding to Nocardia abscessus (Brown-Elliott et al., 2006) . Isolates with type VI patterns were shown to be N. cyriacigeorgica (Conville & Witebsky, 2007) , although N. cyriacigeorgica may be susceptible to ampicillin (Brown-Elliott et al., 2006) and ciprofloxacin (Barnaud et al., 2005) .
Reports of the relative frequency of isolation of N. cyriacigeorgica among clinically significant Nocardia show similar rates in both Europe and Asia. In Belgium, N. cyriacigeorgica accounts for 15 % of Nocardia isolates, third after Nocardia farcinica and Nocardia nova (Wauters et al., 2005) . In Spain, it accounts for 22 % of isolates, equal second with N. abscessus, after N. farcinica (Muñoz et al., 2007) . In Japan 10 % of Nocardia are N. cyriacigeorgica, the fourth most common species after N. farcinica, N. asteroides sensu stricto and N. nova (Kageyama et al., 2004) ; while in Thailand N. cyriacigeorgica is the third most frequently isolated Nocardia after N. farcinica and Nocardia beijingensis, comprising 14 % of isolates (Poonwan et al., 2005) . In the southern USA N. asteroides drug type VI is the most frequently reported Nocardia (Brown-Elliott et al., 2006) , while N. cyriacigeorgica infection has also been reported from Turkey (Akcaglar et al., 2008; Alp et al., 2006) , Greece (Maraki et al., 2006) , France (Barnaud et al., 2005) , Canada (Elsayed et al., 2006) , the USA (Schlaberg et al., 2008) , India (Lalitha et al., 2007) and Germany (Fux et al., 2003) , suggesting a worldwide distribution of potentially pathogenic strains. and abdominal pain. Her polymyalgia rheumatica had been diagnosed within the previous 6 months, following which she had had a reducing course of oral prednisolone. On presentation she was tachycardic, hypotensive and hypoxic, with bilateral crepitations and reduced air entry at the right lung base. Her white cell count was 23610 9 cells l 21 (normal range 3.6-11.0610 9 cells l 21 ), her C-reactive protein level was 289 mg l 21 (normal range 0-10 mg l 21 ) and a chest X-ray showed consolidation of the left lower lobe. In addition to her respiratory symptoms she had left iliac fossa tenderness with a sinus discharging yellow fluid in the right iliac fossa. A soft fluctuant swelling was noted on her left flank. Her heart sounds were normal with no murmurs detected. She was on oral steroids at the time of admission, and was taking clarithromycin following a completed course of flucloxacillin taken whilst in the community. A diagnosis of pneumonia was made, and she was commenced on intravenous cefuroxime and metronidazole (changed after 5 days to oral amoxicillin). At the same time hydrocortisone was prescribed. Fluid from the sinus was processed according to a local standard operating procedure (SOP), based on the relevant national SOP (HPA, 2006) . Cultures on blood agar (aerobic incubation at 36 u C for 48 h), cysteine lactose electrolyte deficient agar (CLED) (aerobic incubation at 36 u C for 24 h), neomycinfastidious anaerobe agar (neoFAA) and vancomycin/ nalidixic acid-fastidious anaerobe agar (vnFAA) (both anaerobic incubation at 36 u C for 48 h) all yielded no growth. She was subsequently diagnosed with a hospitalacquired pneumonia when her condition deteriorated after 1 week in hospital, and was treated with intravenous piperacillin/tazobactam. Two weeks after admission a 3 cm abscess was noted on her right forearm. This was incised and drained, and 10 ml pus was expressed. The following day vancomycin was added to her therapy to ensure empirical meticillin-resistant Staphylococcus aureus cover, and the piperacillin/tazobactam treatment was switched to imipenem as she remained short of breath and tachycardic. Pus samples were processed according to a local SOP based on the national SOP (HPA, 2008) . No growth was recovered from the pus sample on blood agar (48 h) or CLED (24 h), or on neoFAA or vnFAA (5 days), and so vancomycin was stopped after 3 days, with the imipenem being stopped3 days later.
Four days after drainage of the forearm abscess a fluctuant swelling of the left thigh was noted. An earlier ultrasound scan arranged by her general practitioner had shown an extensive tear of the rectus femoris. One week later a repeat scan demonstrated the presence of a large loculated abscess involving much of the anterior compartment of the thigh. Aspiration was performed and samples sent to the microbiology laboratory, where they were processed according the local SOP. No antibiotics were prescribed as the abscess had been drained, but an echocardiogram was recommended. During the next 3 days further swellings were noted on the anterior chest wall and the right forearm. She again showed evidence of systemic sepsis, and vancomycin and imipenem therapy was given for 24 h.
Samples from the thigh abscess yielded Gram-positive bacilli on blood agar after 48 h of aerobic culture. The patient was restarted on vancomycin treatment, which was then changed to piperacillin/tazobactam after 3 days, before being changed to oral doxycycline. The organism was initially identified as a Rhodococcus species using an API Coryne test strip (bioMérieux) (P594.1 %, T51.0), but as this identification method is known to be less reliable for rhodococci and related genera (Almuzara et al., 2006) the isolate was sent to the Centre for Infections at Colindale, London, for confirmation of both identity and antibiotic susceptibilities. Partial 16S rRNA gene sequencing (Bosshard et al., 2003) identified the isolate as N. cyriacigeorgica. The organism was reported to be susceptible to tetracycline, erythromycin, gentamicin and imipenem, but resistant to penicillin, ciprofloxacin, teicoplanin, vancomycin, rifampicin and fusidic acid. Pus from the anterior chest wall abscess also grew N. cyriacigeorgica. Over this period the patient had a fluctuant clinical condition, having intermittent periods of haemodynamic instability associated with pyrexia. Her white cell count and C-reactive protein level remained persistently elevated. A transthoracic echocardiogram demonstrated a thickening of a mitral valve leaflet with a small mobile mass on the apical four-chamber view, suggestive of endocarditis. The patient died 56 days after admission, 2 days after this mass was identified. There was no post-mortem examination, the cause of death being given as infective endocarditis on the death certificate.
Discussion
We have reported here a case of possible endocarditis due to N. cyriacigeorgica. The patient had a major Dukes criterion (Baddour et al., 2005 ) (echocardiographic lesions) and multiple abscesses, which were felt to be consistent with a possible cardiac source (hence the recommendation for echocardiography during the admission). No other bacterial species were isolated from the lesions to suggest a possible mixed infection, and no organisms were ever recovered from blood culture. Only two blood cultures were received from the clinical team during the admission, both before the possibility of endocarditis was raised, and so they were only incubated for 7 days (Becton Dickinson Bactec 9240 automated blood culture system); four sets of cultures received in the previous 3 months were also negative after 7 days. The use of steroids over the course of several months may have masked the presence of minor Dukes criteria for endocarditis. The negative culture results from the initial iliac fossa sinus sample could have been due to insufficient culture time (over 48 h could have been necessary), and from the forearm abscess sample due to the preceding antimicrobial treatment. N. cyriacigeorgica has been described from cases of septicaemia (Elsayed et al., 2006) , brain abscess (Alp et al., 2006; Barnaud et al., 2005; Fux et al., 2003) , pleural empyema (Maraki et al., 2006) , pulmonary infection (Akcaglar et al., 2008; Kageyama et al., 2005; Schlaberg et al., 2008) and keratitis (Lalitha et al., 2007) . Many of these infections occur against a background of immunosuppression, for example chronic lymphocytic leukaemia (Elsayed et al., 2006) , follicular non-Hodgkin's lymphoma (Elsayed et al., 2006) , human immunodeficiency virus infection (Barnaud et al., 2005; Kageyama et al., 2005) or corticosteroid therapy (as in this case) (Akcaglar et al., 2008; Kageyama et al., 2005; Maraki et al., 2006; Muñoz et al., 2007) . Pulmonary infection has been reported in association with a number of predisposing lung conditions (Kageyama et al., 2005; Muñoz et al., 2007) , including cancer, tuberculosis and bronchiectasis.
Nocardia endocarditis
Nocardia spp. are a rare cause of endocarditis (Brouqui & Raoult, 2001) ; 16 cases of endocarditis with Nocardia isolates have been described in the literature since 1970, and are shown in Table 1 . Molecular testing of suspected cases of endocarditis showed 1 of the 22 positive cases to be caused by a Nocardia species (Nocardia paucivorans) (Breitkopf et al., 2005) , while a case series of endocarditis in renal transplant recipients reported 1 of 12 cases identified was caused by a Nocardia species (N. asteroides) (Bishara et al., 1999) . Nocardia endocarditis has a high mortality, with 41 % of cases (7 of 17 including this report) resulting in death. Nine cases (53 %) were associated with prosthetic valves, either with the valve itself (Ayral et al., 1989; Chedid et al., 2007; Daikos et al., 2003; Falk et al., 1979; Vlachakis et al., 1973) or with infection at the site of valve surgery (Allevato et al., 1985; Eigel et al., 1988; Ertl et al., 1987) . Several patients underwent surgery to replace a native valve (Antony et al., 2006; Chain et al., 2007; Lazo Torres et al., 2004; Watson et al., 2001) or prosthetic valve (Eigel et al., 1988; Ertl et al., 1987) ; in each case a successful outcome was reported in combination with antibiotic therapy. Valve replacement has been successful after the infection relapsed following antibiotic therapy (Eigel et al., 1988) . Successful conservative management with antibiotic therapy alone has been reported (Antonovich et al., 2004; Chedid et al., 2007; Daikos et al., 2003) . All but two of the successful treatments involved use of an aminoglycoside after Nocardia was identified as the infective agent (Ayral et al., 1989; Chedid et al., 2007; Chain et al., 2007; Daikos et al., 2003; Lazo Torres et al., 2004; Watson et al., 2001; Daikos et al., 2003; Eigel et al., 1988) , with only one (Ayral et al., 1989) not combining a carbapenem with the aminoglycoside, and one (Antony et al., 2006) using a carbapenem but not an aminoglycoside. Only one (Eigel et al., 1988) did not complete treatment with cotrimoxazole. The remaining case (Antonovich et al., 2004) was treated with co-trimoxazole alone. Infection of an aortic aneurysm not associated with prosthetic materials has also been reported (Gates et al., 2006) . N. cyriacigeorgica should be susceptible to imipenem (Brown-Elliott et al., 2006) , which had been an intermit-tent component of the antibiotic therapy received by our patient since early in her admission. Combination amikacin and ceftriaxone therapy followed by a long course of ceftriaxone alone has been successful in treating pulmonary N. cyriacigeorgica infection (Alp et al., 2006) , although the same combination was unsuccessful in treating a pleural empyema (Maraki et al., 2006) , as was imipenem in pulmonary infection (Akcaglar et al., 2008) . Combination imipenem, amikacin and ciprofloxacin, followed by co-trimoxazole and amoxicillin, has been used to successfully treat a brain abscess (Barnaud et al., 2005) , while combination meropenem and co-trimoxazole has been used in disseminated infection (Elsayed et al., 2006) .
Rhodococcus endocarditis
Endocarditis due to Rhodococcus has been reported rarely. Maltez et al. (1996) reported a case of mitral valve endocarditis in an human immunodeficiency virus positive patient. McNeil & Brown (1992) reported that 1 of their 107 clinical isolates was from a heart valve, while Torres-Tortosa et al. (2003) reported 1 isolate from the heart (otherwise unspecified) in their series of 67 patients. Bacteraemia has been reported more frequently, but in the few cases where echocardiography has been reported (Alric et al., 2002; Gabriels et al., 2006; Kedlaya et al., 2001; Tuon et al., 2007) the results have not indicated endocarditis.
Dietzia endocarditis
No cases of endocarditis have been reported due to Dietzia species, although bacteraemia (Bemer-Melchior et al., 1999) , intra-vascular infection (Reyes et al., 2006) and infection of prosthetic material (Pidoux et al., 2001) have all been reported due to Dietzia maris.
Tsukemurella endocarditis
A single case of infection of prosthetic cardiac material due to Tsukamurella was identified in the literature: an infection of an implanted cardioverter-defibrillator (Almehmi et al., 2004) . Tsukamurella was isolated from lead tip after removal of the device, and the patient was successfully treated with vancomycin and ciprofloxacin. Bacteraemia has been reported more frequently, often in association with central venous catheters (Bouza et al., 2009; Chong et al., 1997; Jones et al., 1994; Schwartz et al., 2002; Shapiro et al., 1992; Sheridan et al., 2003) , but no cases of valve infection.
Gordonia endocarditis
Two cases of endocarditis due to Gordonia species have been reported: one due to Gordonia polyisoprenivorans (Verma et al., 2006) and one that appeared related to Gordonia sputi (Lesens et al., 2000) . Both cases involved native valves, either the aortic (Verma et al., 2006) or mitral (Lesens et al., 2000) , and were associated with long- (Lesens et al., 2000) ; the second case was unsuccessfully treated (Verma et al., 2006) .
Summary
A review of these organisms is complicated by taxonomic changes both within species, for example within the N. asteroides complex (Brown-Elliott et al., 2006) , and between genera, for example Corynebacterium equi changed to Rhodococcus equi (Prescott, 1991) , and reversals of previous changes, for example the incorporation of Gordona into Rhodococcus before a divergence again to Gordonia (Prescott, 1991; Stackebrandt et al., 1997) . Misidentification of these isolates is also common, for example N. cyriacigeorgica identified as a Rhodococcus species (this report), Tsukamurella as Mycobacterium (Alcaide et al., 2004) or Nocardia (Sheridan et al., 2003) , Rhodococcus as Corynebacterium (Tuon et al., 2007) , or Gordonia as Nocardia or Rhodococcus (Blaschke et al., 2007) . For this reason this discussion has been limited to those cases where a bacterial isolate was reported, rather than histological reports of 'Nocardia-like' organisms (Dhawan et al., 1998) . Other morphologically similar organisms (loosely classified as aerobic actinomycetes) may also cause endocarditis, for example Oerskovia (Ellerbroek et al., 1998) and Rothia (Ricaurte et al., 2001) species, but are more distantly related to the Corynebacterineae (Stackebrandt et al., 1997) . The changing taxonomies make the continued reporting of cases with the best possible identification important.
N. cyriacigeorgica has been described as 'an emerging pathogen in the United States' (Schlaberg et al., 2008) , but might be better considered as 'a newly named but longrecognised agent of human disease' (Conville & Witebsky, 2007) . We add this case report to the growing literature to help characterize the clinical spectrum of disease associated with N. cyriacigeorgica with the increased discrimination now available for the identification of Nocardia species. We believe this is the first report of endocarditis associated with N. cyriacigeorgica as a named species in the English literature, and reinforce the suggestion that the possibility of endocarditis cannot be excluded in patients with disseminated Nocardia infection.
